|
Category:natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 38.00 to 39.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 244.00 to 245.00 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.005000 mmHg @ 25.00 °C. (est) |
| Flash Point: | 220.00 °F. TCC ( 104.50 °C. ) (est)
|
| logP (o/w): | 0.995 (est) |
| Soluble in: |
| | alcohol | | | water, 1726 mg/L @ 25 °C (est) |
| Insoluble in: |
| | water |
Organoleptic Properties:
| Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intraperitoneal-rat LDLo 400 mg/kg
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Annales Pharmaceutiques Francaises. Vol. 9, Pg. 338, 1951.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 500 mg/kg
BEHAVIORAL: COMA
KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Annales Pharmaceutiques Francaises. Vol. 9, Pg. 338, 1951.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | | natural substances and extractives |
| Recommendation for oxypinocamphone usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for oxypinocamphone flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | bicyclo(3.1.1)heptan-3-one, 2-hydroxy-2,6,6-trimethyl- (9CI) | | | bicyclo[3.1.1]heptan-3-one, 2-hydroxy-2,6,6-trimethyl- | | | camphostene | | 2- | hydroxy-2,6,6-trimethyl bicyclo(3.1.1)heptan-3-one | | 2- | hydroxy-2,6,6-trimethylbicyclo(3.1.1)heptan-3-one | | 2- | hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one | | 2- | hydroxy-3-pinanone | | 4- | hydroxy-4,6,6-trimethylbicyclo[3.1.1]heptan-3-one | | 2- | hydroxypinan-3-one | | 2- | hydroxypinocamphone | | 3- | hydroxypinocamphone | | | pinan-3-one, 2-hydroxy- | | 3- | pinanone, 2-hydroxy- | | oxy | pinone |
Articles:
| PubMed:Synthesis of 2-(pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, a class of potent nicotinic acetylcholine receptor-ligands. |
| PubMed:A general, efficient and stereospecific route to sphingosine, sphinganines, phytosphingosines and their analogs. |
| PubMed:A general procedure for the enantioselective synthesis of the minor tobacco alkaloids nornicotine, anabasine, and anatabine. |
| PubMed:Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA. |
| PubMed:Full stereochemical understanding in a new (2R,3R,4R)-4-hydroxyisoleucine synthesis. |
| PubMed:Two key chiral intermediates in a new 4-hydroxyisoleucine synthesis. |
| PubMed:Some of the amino acid chemistry going on in the Laboratory of Amino Acids, Peptides and Proteins. |
| PubMed:A novel enantioselective synthesis of (S)-(-)- and (R)-(+)-nornicotine via alkylation of a chiral 2-hydroxy-3-pinanone ketimine template. |
| PubMed:Syntheses ofγ-fluoro-α-amino acids. |
| PubMed:[Pharmacodynamics of oxypinocamphone]. |
|
3D/inchi